MS biotech Forward Pharma files for a $200 million IPO

By
A A A

Forward Pharma A/S, a late-stage biotech developing treatments for multiple sclerosis and psoriasis, filed on Monday with the SEC to raise up to $200 million in an initial public offering.

The Copenhagen, Denmark-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol FWP. Forward Pharma A/S initially filed confidentially on April 9, 2014. Leerink Partners is the sole bookrunner on the deal. No pricing terms were disclosed.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks:

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

13,719,674
  • $18.015 ▲ 0.19%
12,917,987
  • $113.444 ▲ 1.28%
11,932,133
  • $7.46 ▲ 2.75%
11,109,884
  • $8.34 ▲ 5.70%
10,018,834
  • $93.71 ▲ 2.65%
9,725,330
  • $7.50 ▼ 1.32%
9,022,639
  • $68.93 ▲ 3.79%
7,877,345
  • $10.71 ▲ 3.88%
As of 12/26/2014, 01:00 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com